Cell & Gene Therapy - Scientists discover how muscle stem cells "flip a switch" to rebuild damaged muscle
View as a Web Page
News Medical
 
  Cell & Gene Therapy Cell & Gene Therapy logo  
  The latest stem cells news from News Medical  
 

Why do some transient transfections outperform others?Why do some transient transfections outperform others?

Transient transfection efficiency depends strongly on how DNA-reagent complexes form, grow, and stabilize. This article compares leading transfection reagents using SR-DLS and shows how real-time particle size monitoring can help improve process insight, consistency, and viral vector production outcomes.

Read the article
 
   Scientists discover how muscle stem cells "flip a switch" to rebuild damaged muscleScientists discover how muscle stem cells "flip a switch" to rebuild damaged muscle
 
Scientists at the University of California, Irvine's School of Pharmacy & Pharmaceutical Sciences have discovered how muscle stem cells "flip a switch" to rebuild damaged muscle – a finding that could help address muscle loss linked to aging, injury and widely used weight-loss medications.
 
   New biotech partnership aims to accelerate stem cell therapies for heart diseaseNew biotech partnership aims to accelerate stem cell therapies for heart disease
 
A new biotech company forged through an Australian and Danish partnership will accelerate treatments for children and adults with heart disease. Harnessing cellular therapies, the company aims to conduct human clinical trials within three to five years.
 
 Researchers discover protein that promotes natural dental pulp tissue regeneration
 
Researchers discover protein that promotes natural dental pulp tissue regenerationDental pulp injury caused by trauma or deep caries often leads to inflammation, tissue necrosis, and eventual loss of tooth vitality.
 
 
 New CAR-NKT cell therapy shows promise against aggressive endometrial cancer
 
New CAR-NKT cell therapy shows promise against aggressive endometrial cancerEndometrial cancer is the most common gynecologic cancer in the United States and is one of the few cancers in which survival rates have steadily declined over the last few decades.
 
 
 FDA approves first gene therapy for rare pediatric immune disorder
 
FDA approves first gene therapy for rare pediatric immune disorderDr. Donald Kohn has been developing gene therapies for rare pediatric immune disorders for over 30 years.
 
 
 Chronic colitis reshapes colon stem cells in ways that can accelerate tumour growth
 
Chronic colitis reshapes colon stem cells in ways that can accelerate tumour growthResearchers showed that chronic colitis leaves a long-lasting epigenetic memory in colonic stem cells, persisting for more than 100 days after recovery in mice. This memory is marked by durable AP-1-linked chromatin changes and later amplifies tumour outgrowth after oncogenic mutation.
 
 
 Machine learning helps predict risks during stem cell therapy for myeloma
 
Machine learning helps predict risks during stem cell therapy for myelomaMultiple myeloma is a cancer in which plasma cells, which normally produce antibodies, multiply uncontrollably in the bone marrow.
 
 
 New MRI method tracks transplanted heart stem cells for months
 
New MRI method tracks transplanted heart stem cells for monthsResearchers at the Institute of Biomedical Engineering at the University of Toronto have demonstrated a new way to monitor transplanted stem-cell-derived heart cells using magnetic resonance imaging (MRI).
 
 
 New CAR-T cell therapy shows promise for treating osteosarcoma
 
New CAR-T cell therapy shows promise for treating osteosarcomaFinding an effective treatment for osteosarcoma, the most common type of bone cancer in children and young adults, has puzzled medical researchers for 40 years.
 
 

How would you rate today's newsletter?

 
             
 
 
Google News Icon Stay updated with the latest in health and medical news! Follow News‑Medical.net on Google News for real‑time updates. Click here to follow us now.
 
Facebook X Instagram LinkedIn Vimeo
Why did you receive this email?
You are receiving this email because you subscribed to updates from AZoNetwork UK Ltd. on one of our websites and requested to be notified of additional information.

Unsubscribe or Update Notification Preferences

Contact | About | Privacy Policy

- - - - - -

Registered Address:
AZoNetwork UK Ltd., NEO, 9 Charlotte St, Manchester, M1 4ET, UK

Manchester | Sydney | Boston

Copyright © 2000-2026